A blog today in The BMJ provides further commentary on predatory journals. The blog provides a good overview of how to recognise predatory journals, and provides a variety of tips. … Continue Reading Predatory journals – a bad dream turning into a nightmare (BMJ Blog by @jocalynclark)
What can we do to increase trust in peer review? How can we encourage more researchers to take part in peer review? These were just some of the issues considered … Continue Reading Righting peer review: Are trust and incentives the key?
Transforming the subscription journals’ business model to facilitate the necessary large-scale transformation to open access
A Max Planck Digital Library Open Access Policy White Paper published this week makes a case for a large-scale transformation of the current corpus of scientific subscription journals to an … Continue Reading Transforming the subscription journals’ business model to facilitate the necessary large-scale transformation to open access
The AllTrials campaign calls for all past and present clinical trials to be registered and their full methods and summary results reported. At the recent Evidence Live congress, Sir Iain … Continue Reading Presentation on the #AllTrials campaign (to register and report findings from all clinical trials)
Revised guidelines relating to the development of medical publications to be published in the near future (GPP-3)
Most people involved in the development of medical publications – and particularly those from industry – are familiar with the Good Publication Practice (GPP)-2 guidelines, which were published in 2009. … Continue Reading Revised guidelines relating to the development of medical publications to be published in the near future (GPP-3)
In this short video from the ISMPP 2015 annual meeting, Daniel Shanahan (Associate Publisher at BioMed Central) discusses patient peer review and BioMed Central’s decision to include patients in the … Continue Reading Involvement of patients in the journal peer review process
An editorial in the Cochrane Library from the last week argues that clinical trial information from regulators should be included in systematic reviews of treatments. In 2014, the authors of … Continue Reading Should regulatory data from the EMA and the FDA be included in systematic reviews?
A new report, written by Nordic clinical trial experts, sets a high international standard for clinical trial transparency and sets out how to make it a reality. The report from … Continue Reading Nordic researchers want to lead the world in clinical trial transparency
What exactly is a Digital Object Identifier (DOI) and how does it help in the management and long-term preservation of research? A blog by The London School of Economics and … Continue Reading Digital Object Identifiers: stability for citations and referencing, but not proxies for quality
Recently, COPE held a seminar on metrics and how they shape publication (mis)behavior. A blog published in the past few days by BioMed Central (and written by Elizabeth Moylan) provides … Continue Reading Are metrics meaningful? A blog from BioMed Central (@biomedcentral)
An educational afternoon meeting will be held at Alderley Park in Cheshire on the 3rd of June, entitled: “An update: Publications in Practice”. The programme for this meeting is now … Continue Reading Free educational meeting on medical publications in Cheshire, UK on 3rd June
In a blog today, Iain Hrynaszkiewicz – the Head of Data and HSS Publishing at Nature Publishing Group and Palgrave Macmillan – provides a publisher’s views on improving the reproducibility … Continue Reading The role of openness and publishers in reproducible research
In an article in Trials this week, investigators from the Medical Research Council (MRC) Clinical Trials Unit at the University College London (UCL) provide an overview of their experiences of … Continue Reading Considerations relating to sharing data from clinical trials
The World Health Organization (WHO) today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. The move aims to ensure … Continue Reading WHO announces new statement on public reporting of clinical trial results